Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NCT01976364 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

686

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Psoriatic

Interventions

DRUG: Tofacitinib
DRUG: Tofacitinib
DRUG: Methotrexate
DRUG: Placebo Methotrexate

Sponsor

Pfizer